-+ 0.00%
-+ 0.00%
-+ 0.00%
Can 3M (MMM) Trade At A Discount After UBS Growth Call?
Share
Listen to the news

3M has delivered a very strong 138.2% share price gain over the past three years, which puts a bright spotlight on one thing: whether the current US$177.99 price can be backed up by the cash the business is expected to generate. With upbeat commentary around its earnings potential running well into the next decade, investors are increasingly asking how that story lines up with an intrinsic value grounded in hard cash flows rather than sentiment.

  • The 138.2% return over three years means anyone looking at 3M today is effectively being asked to pay a much higher price for the same underlying cash flow stream than they were a few years ago, so the link between that stream and the share price matters more than ever.
  • UBS now expects stronger earnings and margin expansion helped by productivity gains, pricing and a shift toward more customer-focused product development, which can support higher and more durable cash generation if execution matches those expectations.
  • If you'd rather focus on earnings, this one's for you. See why 3M's 26.0x P/E tells a different valuation story.

The issue now is whether 3M's current share price lines up with its intrinsic value when that value is estimated using a Discounted Cash Flow (DCF) view of the cash the company can return over time.

If you are weighing whether 3M's 138.2% three year return is justified by its cash flows, it can help to compare that story with companies in the 40 high quality undervalued stocks.

Does 3M Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) view here focuses on the cash that 3M can realistically return to shareholders over time. Latest twelve month free cash flow sits at about $2.6b, with the model assuming that this stream progresses into a growing profile over the next decade rather than shrinking.

Those projections build toward annual free cash flow in the mid 4b to mid 5b range by 2030, which is then discounted back using the 2 Stage Free Cash Flow to Equity approach. The outcome is an estimated intrinsic value that the model suggests is meaningfully above the current US$177.99 share price. Because UBS is highlighting potential earnings and margin gains through 2030, the outlook on profitability helps explain why the cash flow based value comes out higher than where the market is pricing 3M today. Find out what 3M could be worth using our Discounted Cash Flow (DCF) estimate.

The 3M Narrative: What Would Justify Today's Price?

3M's valuation story raises a clear question. What specific future path for growth, margins and earnings would need to hold for the current pricing to look too low or too rich? Simply Wall St Narratives pick up that thread by spelling out those underlying assumptions and turning each into a thesis about 3M's business that can be tracked over time. They sit on the stock's Community page for investors who want to see how that thesis holds up.

Views on 3M split between those who think self help and new markets still are not fully priced in and those who see the risks already capping upside.

Bull case: 7% undervalued

The analyst consensus Narrative on Simply Wall St frames the constructive view on 3M in one tight line.

"The current valuation implies the share price does not fully reflect 3M’s higher organic growth guidance, raised EPS and free cash flow outlook..."

Discover why this Narrative puts 3M at 7% undervalued.

Bear case: 26% overvalued

The bearish analyst Narrative on Simply Wall St distills the more cautious stance around 3M into a single concern.

"New environmental actions, including New York’s wide ranging PFAS lawsuit seeking cleanup funding, damages, and penalties, sit on top of other environmental and safety cases..."

Explore why this Narrative puts 3M at 26% overvalued.

Before you act on 3M’s valuation, there is one more piece to check

Beyond cash flows and market narratives, Simply Wall St’s broader review has flagged specific concerns about 3M that investors may want to weigh alongside the upside story. Take a closer look at 2 warning signs before settling on a valuation.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending